ArticleJournal for immunotherapy of cancer2019

Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival.

Carlo Sorrentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.